Virus-Like Particle: Evolving Meanings in Different Disciplines
- 17 March 2021
- journal article
- editorial
- Published by SAGE Publications in PHAGE: Therapy, Applications, and Research
- Vol. 2 (1) , 11-15
Abstract
Virus-like particle (VLP) is a term that has been in use for about 80 years. Usually, VLP has meant a particle that is like a virus, generally by appearance, but without either proven or actual virus functionality. Initially VLP referred to particles seen in electron microscope images of tissues. More recently, VLP has come to mean other things to other researchers. A key divergence has been use of VLP in association with vaccine and biotechnology applications versus use of VLP in enumeration of viruses in environmental samples. To these viral ecologists, a VLP is a particle that is virus sized, has nucleic acid, and could be a functional virus. But to vaccine developers and biotechnology researchers a VLP instead is a viral structure that intentionally lacks a viral genome. In this study, we look at the history of use of VLP, following changes in meaning as the technology to study VLPs changed.Keywords
This publication has 66 references indexed in Scilit:
- Characterization of Persistent Virus-Like Particles in Two Acetate-Fed Methanogenic ReactorsPLOS ONE, 2013
- Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivityVirology Journal, 2012
- Protein delivery using engineered virus-like particlesProceedings of the National Academy of Sciences, 2011
- Cell-Specific Delivery of Diverse Cargos by Bacteriophage MS2 Virus-like ParticlesACS Nano, 2011
- RNA‐Directed Packaging of Enzymes within Virus‐like ParticlesAngewandte Chemie International Edition, 2010
- Formulation of Microneedles Coated with Influenza Virus-like Particle VaccineAAPS PharmSciTech, 2010
- Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor bindingProceedings of the National Academy of Sciences, 2009
- Core-controlled polymorphism in virus-like particlesProceedings of the National Academy of Sciences, 2007
- High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upBritish Journal of Cancer, 2006
- Requirements for the Assembly and Release of Newcastle Disease Virus-Like ParticlesJournal of Virology, 2006